← Open Payments lookup

PHILLIP SCOTT: Open Payments

NPI 1235125816 · RICHMOND, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$743 in 38 payments from 18 companies in 2025. Trend: 2023 $433 · 2024 $445 · 2025 $743

Food & beverage: $693Long term medical supply or device loan: $50
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)6$103
Lundbeck LLC5$100
Astellas Pharma US Inc4$91
Teva Pharmaceuticals USA, Inc.3$71
Abbott Laboratories2$64
Neurocrine BioSciences, Inc.2$39
Axsome Therapeutics, Inc.2$37
ABBVIE INC.2$37
Novo Nordisk Inc2$36
Eisai Inc.2$32

Products named: CAPLYTA, REXULTI, Veozah, AUSTEDO XR, FREESTYLE INSULINX, INGREZZA, Auvelity, Leqembi.

Industry payments across IN — which companies pay providers there.